07 – 10 October 2026 | AIPPI World Congresses
2026 AIPPI World Congress
SAVE THE DATE for the 2026 AIPPI World Congress in Hamburg
Read more
13 – 16 September 2025 | AIPPI World Congresses
2025 AIPPI World Congress
SAVE THE DATE for the 2025 AIPPI World Congress in Yokohama
Read more
20 – 21 February 2025 | Other
2025 AIPPI MidTerm Meeting
REGISTER NOW for the 2025 AIPPI MidTerm Meeting
Read more
09 December 2024 | Webinar
Register now for the AIPPI Germany Young Members Webinar on 9 December
Ready to dive deeper into the AI landscape with young experts? Join us on 9 December (9:00-14:30 CET) for the AIPPI Germany Young Members Webinar on 'AI in IP - from Patenting to Infringement'.
Read more
28 November 2024 | Webinar
AIPPI Swiss Group Webinar about the 2024 Study Questions and Resolutions
Are you interested in learning more about the AIPPI Study Questions & Resolutions from the 2024 AIPPI World Congress in Hangzhou, China? Join us for a webinar from AIPPI Switzerland on 28 November (17:00-18:30 CET) for a thorough analysis of these important topics (General, Patents, Copyrights and Trade Marks).
Read moreYou may also be interested in these contents
18.11.24 | Newsletter
Greetings from the new Reporter General of AIPPI
As the new Reporter General, I would like to thank you for electing me to this leadership position – thank you for your trust and encouragement. I am very grateful that I can work with six other members of the Reporter General Team, who are all highly ranked and leading international practitioners, namely Guillaume Henry (FR, First Deputy Reporter General), Johanna Flythström (FI, Second Deputy Reporter General), as well as Rafael Atap (BR), Klaudia Blach-Morysinska (PL), Mamta Rani Jha (IN), and Yanfeng Xiong (CN) as Assistants to the Reporter General.
Read more18.11.24 | Newsletter
CJEU clarifies “First” Marketing Authorization in SPC Applications
A Supplementary Protection Certificate (SPC) is an intellectual property right that serves as an extension to a patent right. It extends patent protection for medicinal products which must undergo testing and clinical trials before being authorised to be placed on the EU market.
Read more